Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review. | Diagnostics (Basel) | 2023 | 36672993 | PubTator, text mining | PubMed |
| Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression. | Cells | 2023 | 36672169 | PubTator, text mining | PubMed |
| Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center Analysis. | Brain Sci | 2023 | 36672091 | PubTator, text mining | PubMed |
| Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. | RNA | 2023 | 36669889 | PubTator, text mining | PubMed |
| Comprehensive SMN1 and SMN2 profiling for spinal muscular atrophy analysis using long-read PacBio HiFi sequencing. | Am J Hum Genet | 2023 | 36669496 | PubTator, text mining | PubMed |
| Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis. | J Cyst Fibros | 2023 | 36658041 | PubTator, text mining | PubMed |
| RNAi in cell nuclei: potential for a new layer of biological regulation and a new strategy for therapeutic discovery. | RNA | 2023 | 36657971 | PubTator, text mining | PubMed |
| Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics. | RNA | 2023 | 36653113 | PubTator, text mining | PubMed |
| Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration. | Cell Biosci | 2023 | 36647159 | PubTator, text mining | PubMed |
| Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4. | Brain Commun | 2023 | 36632180 | PubTator, text mining | PubMed |
| Characterizing crosstalk in epigenetic signaling to understand disease physiology. | Biochem J | 2023 | 36630129 | PubTator, text mining | PubMed |
| RNA splicing dysregulation and the hallmarks of cancer. | Nat Rev Cancer | 2023 | 36627445 | PubTator, text mining | PubMed |
| Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. | Funct Integr Genomics | 2023 | 36625940 | PubTator, text mining | PubMed |
| Usefulness of YouTube in Sharing Information about New Gene Therapy for Spinal Muscular Atrophy: A Content Analysis. | Healthcare (Basel) | 2023 | 36611608 | PubTator, text mining | PubMed |
| Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation. | Cell | 2023 | 36608661 | PubTator, text mining | PubMed |
| Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. | Proc Natl Acad Sci U S A | 2023 | 36603028 | PubTator, text mining | PubMed |
| Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study. | J Neuromuscul Dis | 2023 | 36565133 | PubTator, text mining | PubMed |
| Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts. | Protein Sci | 2023 | 36560896 | PubTator, text mining | PubMed |
| Current treatments of spinal muscular atrophy in adults. | Rev Neurol (Paris) | 2023 | 36550013 | PubTator, text mining | PubMed |
| Disease Burden in Children With Spinal Muscular Atrophy: Results From a Large Cross-Sectional Study. | J Child Neurol | 2023 | 36537125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=36